RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bartley Griffith, M.D.
University of Maryland
Principal Investigator - Mark Anderson
Robert Wood Johnson Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Maryland
Baltimore, Maryland, United States
- Brigham & Womens
Boston, Massachusetts, United States
- Massach General Hospital
Boston, Massachusetts, United States
- Robert Wood Johnson
New Brunswick, New Jersey, United States
- Columbia Presbyterian Hospital
New York, New York, United States
- Hershey Medical Center
Hershey, Pennsylvania, United States
- Texas Heart
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 30 Apr 2010
- Completion
- 31 May 2010
- Last update posted
- 27 May 2010
- Registered enrollment
- 17
- Registry id
- NCT00596726
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.